Effects of curcumin on hippocampal expression of NgR and axonal regeneration in Aβ-induced cognitive disorder rats

Genetics and Molecular Research

Volumn 13, Issue 1, 2014, Pages 2039-2047

  Yin, H L ^a   Wang, Y L ^a   Li, J F ^a   Han, B ^a   Zhang, X X ^a   Wang, Y T ^a   Geng, S ^a  

^a PLA 148th Hospital   (China)

Author keywords

Alzheimer's disease; Amyloid protein; Axon; Curcumin; NgR

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; BRAIN RECEPTOR; CURCUMIN; MESSENGER RNA; NOGO RECEPTOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION REGULATION; LATENT PERIOD; MALE; MORRIS WATER MAZE TEST; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NERVE FIBER TRANSPORT; NEUROPATHOLOGY; NGR GENE; NONHUMAN; PROTEIN EXPRESSION; RAT; SPATIAL LEARNING; SPATIAL MEMORY; UPREGULATION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; AXONS; CURCUMIN; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GPI-LINKED PROTEINS; HIPPOCAMPUS; MALE; MAZE LEARNING; MYELIN PROTEINS; RATS; RECEPTORS, CELL SURFACE; RNA, MESSENGER;

EID: 84897945591     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.March.24.8     Document Type: Article

References (26)

1. Belkacemi A, Doggui S, Dao L and Ramassamy C (2011). Challenges associated with curcumin therapy in Alzheimer disease. Expert. Rev. Mol. Med. 13: e34.
2. Burdick D, Soreghan B, Kwon M, Kosmoski J, et al. (1992). Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J. Biol. Chem. 267: 546-554.
3. Chomczynski P (1993). A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15: 532-537.
4. Cole GM, Morihara T, Lim GP, Yang F, et al. (2004). NSAID and antioxidant prevention of Alzheimer's disease: lessons from in vitro and animal models. Ann. N. Y. Acad. Sci. 1035: 68-84.
5. Fournier AE, Takizawa BT and Strittmatter SM (2003). Rho kinase inhibition enhances axonal regeneration in the injured CNS. J. Neurosci. 23: 1416-1423.
6. Paxinos G and Watson C (1998). The Rat Brain in Stereotaxic Coodinate. 4th edn. Academic Press, New York.
7. Gil V, Nicolas O, Mingorance A, Urena JM, et al. (2006). Nogo-A expression in the human hippocampus in normal aging and in Alzheimer disease. J. Neuropathol. Exp. Neurol. 65: 433-444.
8. Giri RK, Rajagopal V and Kalra VK (2004). Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J. Neurochem. 91: 1199-1210.
9. Hardy J and Selkoe DJ (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356.
10. Heneka MT and O'Banion MK (2007). Inflammatory processes in Alzheimer's disease. J. Neuroimmunol. 184: 69-91.
11. Huang HC, Chang P, Dai XL and Jiang ZF (2012). Protective effects of curcumin on amyloid-beta-induced neuronal oxidative damage. Neurochem. Res. 37: 1584-1597.
12. Jiang T, Zhi XL, Zhang YH, Pan LF, et al. (2012). Inhibitory effect of curcumin on the Al(III)-induced Abeta(4)(2) aggregation and neurotoxicity in vitro. Biochim. Biophys. Acta 1822: 1207-1215.
13. Lim GP, Chu T, Yang F, Beech W, et al. (2001). The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 21: 8370-8377.
14. McGee AW and Strittmatter SM (2003). The Nogo-66 receptor: focusing myelin inhibition of axon regeneration. Trends Neurosci. 26: 193-198.
15. Motterlini R, Foresti R, Bassi R and Green CJ (2000). Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic. Biol. Med. 28: 1303-1312.
16. Nakamura S, Murayama N, Noshita T, Annoura H, et al. (2001). Progressive brain dysfunction following intracerebroventricular infusion of beta(1-42)-amyloid peptide. Brain Res. 912: 128-136.
17. Park JH, Gimbel DA, GrandPre T, Lee JK, et al. (2006a). Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition. J. Neurosci. 26: 1386-1395.
18. Park JH, Widi GA, Gimbel DA, Harel NY, et al. (2006b). Subcutaneous Nogo receptor removes brain amyloid-beta and improves spatial memory in Alzheimer's transgenic mice. J. Neurosci. 26: 13279-13286.
19. Perry E and Howes MJ (2011). Medicinal plants and dementia therapy: herbal hopes for brain aging? CNS Neurosci. Ther. 17: 683-698.
20. Ringman JM, Frautschy SA, Cole GM, Masterman DL, et al. (2005). A potential role of the curry spice curcumin in Alzheimer's disease. Curr. Alzheimer Res. 2: 131-136.
21. Thiyagarajan M and Sharma SS (2004). Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci. 74: 969-985.
22. Wang J, Zhang YJ and Du S (2012). The protective effect of curcumin on Abeta induced aberrant cell cycle reentry on primary cultured rat cortical neurons. Eur. Rev. Med. Pharmacol. Sci. 16: 445-454.
23. Wang YH and Du GH (2003). A drug target for Alzheimer's disease: BETA-secretase. Chin. Pharmacol. Bull. 19: 609-613.
24. Xiao F, Lin LF, Cheng X, Gao Q, et al. (2012). Nogo-66 receptor activation inhibits neurite outgrowth and increases beta-amyloid protein secretion of cortical neurons. Mol. Med. Rep. 5: 619-624.
25. Xiong Z, Hongmei Z, Lu S and Yu L (2011). Curcumin mediates presenilin-1 activity to reduce beta-amyloid production in a model of Alzheimer's Disease. Pharmacol. Rep. 63: 1101-1108.
26. Zhu HY, Guo HF, Hou HL, Liu YJ, et al. (2007). Increased expression of the Nogo receptor in the hippocampus and its relation to the neuropathology in Alzheimer's disease. Hum. Pathol. 38: 426-434.